|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Acadia Pharmaceuticals Inc., of San Diego, received a milestone payment tied to the initiation of an exploratory glaucoma clinical trial by partner Allergan Inc., of Irvine, Calif. The trial will evaluate a selective muscarinic small molecule discovered at Acadia. Allergan has responsibility for development and global commercialization of the product and any others emerging from the companies' ocular disease collaboration, while Acadia will receive milestone payments and royalties. (See BioWorld Today, July 28, 1999.)
o Bolder BioTechnology Inc., of Boulder, Colo., received a $762,475 Phase II Small Business Innovation Research (SBIR) grant from the NIH's ...
Related newspaper, magazine, and journal articles:
|
|
Article: MEGABIOS, GENEMEDICINE AGREE TO `STRATEGIC MERGER' THAT POOLS ...
BIOWORLD Today;
October 27, 1998 ;
700+ words
... ... percent, or $0.281. McGraw told BioWorld Today the move is one of the few "strategic ... into GeneMedicine," Weintraub told BioWorld Today. "This merger allows us to simplify ... up relatively early," Waldron told BioWorld Today. "This merger announcement is the ...
|
|